What is Candel Therapeutics, Inc.'s PP&E (net)?

Candel Therapeutics, Inc. (CADL) reported PP&E (net) of $2.08M in Q1 2026.

How has Candel Therapeutics, Inc.'s PP&E (net) changed year-over-year?

Candel Therapeutics, Inc.'s PP&E (net) increased by 5.6% year-over-year, from $1.97M to $2.08M.

What is the long-term trend for Candel Therapeutics, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s PP&E (net) has grown at a -10.0% compound annual growth rate (CAGR), from $2.79M to $1.64M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Candel Therapeutics, Inc. CADL PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers SquibbBMY

$7.66B+6.2%

AmgenAMGN

$8.22B+23.0%

Gilead SciencesGILD

$5.64B+4.0%

Replimune GroupREPL

$13.85M+1.7%

CG OncologyCGON

$15.07M+5,610%

Immix Biopharma, Inc.IMMX

$2.43M+14.3%

Other financials

Income statement

See full

Revenue$31.0K0.0%

Operating income-$16.3M-100%

Net income-$8.9M-220%

EPS (diluted)-$0.14-208%

Balance sheet

See full

Cash & equivalents$194.8M+111%

Total debt$2.8M-73.9%

Total equity$138.0M+84.8%

Total assets$201.9M+111%

Cash flow

See full

Operating cash flow-$18.0M-109%

CapEx$675.0K+22,400%

Free cash flow-$18.7M-117%

Valuation

See full

Market cap$693.87M+192%

Enterprise value$501.88M+220%

P/S5,595.7×-18,674×

Profitability

See full

Operating margin-28,000.8%+15,050pp

Net margin-15,156.5%-5,064pp

FCF margin-26,383.9%+14,851pp

Returns & leverage

See full

Return on equity-51.2%-16.6pp

Debt / equity0×-0.1×

Current ratio28×+23.4×

Where this comes from

Reported directly by Candel Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Candel Therapeutics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Candel Therapeutics, Inc.'s PP&E (net)?: Candel Therapeutics, Inc. (CADL) reported PP&E (net) of $2.08M in Q1 2026.
How has Candel Therapeutics, Inc.'s PP&E (net) changed year-over-year?: Candel Therapeutics, Inc.'s PP&E (net) increased by 5.6% year-over-year, from $1.97M to $2.08M.
What is the long-term trend for Candel Therapeutics, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s PP&E (net) has grown at a -10.0% compound annual growth rate (CAGR), from $2.79M to $1.64M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.